276 related articles for article (PubMed ID: 16012931)
21. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
[TBL] [Abstract][Full Text] [Related]
22. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
[TBL] [Abstract][Full Text] [Related]
23. Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.
Cassada DC; Tribble CG; Long SM; Kaza AK; Linden J; Rieger JM; Rosin D; Kron IL; Kern JA
Ann Thorac Surg; 2002 Sep; 74(3):846-9; discussion 849-50. PubMed ID: 12238849
[TBL] [Abstract][Full Text] [Related]
24. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.
Olson TS; Bamias G; Naganuma M; Rivera-Nieves J; Burcin TL; Ross W; Morris MA; Pizarro TT; Ernst PB; Cominelli F; Ley K
J Clin Invest; 2004 Aug; 114(3):389-98. PubMed ID: 15286805
[TBL] [Abstract][Full Text] [Related]
25. Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping.
Reece TB; Okonkwo DO; Ellman PI; Maxey TS; Tache-Leon C; Warren PS; Laurent JJ; Linden J; Kron IL; Tribble CG; Kern JA
Ann Thorac Surg; 2006 Mar; 81(3):902-9. PubMed ID: 16488692
[TBL] [Abstract][Full Text] [Related]
26. Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.
Rivera-Nieves J; Bamias G; Vidrich A; Marini M; Pizarro TT; McDuffie MJ; Moskaluk CA; Cohn SM; Cominelli F
Gastroenterology; 2003 Apr; 124(4):972-82. PubMed ID: 12671894
[TBL] [Abstract][Full Text] [Related]
27. In vivo demonstration of T lymphocyte migration and amelioration of ileitis in intestinal mucosa of SAMP1/Yit mice by the inhibition of MAdCAM-1.
Matsuzaki K; Tsuzuki Y; Matsunaga H; Inoue T; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S
Clin Exp Immunol; 2005 Apr; 140(1):22-31. PubMed ID: 15762871
[TBL] [Abstract][Full Text] [Related]
28. Adenosine A(2A) receptor stimulation reduces inflammation and neointimal growth in a murine carotid ligation model.
McPherson JA; Barringhaus KG; Bishop GG; Sanders JM; Rieger JM; Hesselbacher SE; Gimple LW; Powers ER; Macdonald T; Sullivan G; Linden J; Sarembock IJ
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):791-6. PubMed ID: 11348876
[TBL] [Abstract][Full Text] [Related]
29. Targeted inhibition of heat shock protein 90 suppresses tumor necrosis factor-α and ameliorates murine intestinal inflammation.
Collins CB; Strassheim D; Aherne CM; Yeckes AR; Jedlicka P; de Zoeten EF
Inflamm Bowel Dis; 2014 Apr; 20(4):685-94. PubMed ID: 24552830
[TBL] [Abstract][Full Text] [Related]
30. Blockade of PSGL-1 attenuates CD14+ monocytic cell recruitment in intestinal mucosa and ameliorates ileitis in SAMP1/Yit mice.
Inoue T; Tsuzuki Y; Matsuzaki K; Matsunaga H; Miyazaki J; Hokari R; Okada Y; Kawaguchi A; Nagao S; Itoh K; Matsumoto S; Miura S
J Leukoc Biol; 2005 Mar; 77(3):287-95. PubMed ID: 15569697
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice.
Takedatsu H; Mitsuyama K; Matsumoto S; Handa K; Suzuki A; Takedatsu H; Funabashi H; Okabe Y; Hara T; Toyonaga A; Sata M
Eur J Immunol; 2004 Jun; 34(6):1561-9. PubMed ID: 15162425
[TBL] [Abstract][Full Text] [Related]
32. Commensal bacteria exacerbate intestinal inflammation but are not essential for the development of murine ileitis.
Bamias G; Okazawa A; Rivera-Nieves J; Arseneau KO; De La Rue SA; Pizarro TT; Cominelli F
J Immunol; 2007 Feb; 178(3):1809-18. PubMed ID: 17237431
[TBL] [Abstract][Full Text] [Related]
33. Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice.
Gorfu G; Rivera-Nieves J; Hoang S; Abbott DW; Arbenz-Smith K; Azar DW; Pizarro TT; Cominelli F; McDuffie M; Ley K
J Immunol; 2010 Nov; 185(9):5561-8. PubMed ID: 20926792
[TBL] [Abstract][Full Text] [Related]
34. STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.
Mitsuyama K; Matsumoto S; Rose-John S; Suzuki A; Hara T; Tomiyasu N; Handa K; Tsuruta O; Funabashi H; Scheller J; Toyonaga A; Sata M
Gut; 2006 Sep; 55(9):1263-9. PubMed ID: 16682432
[TBL] [Abstract][Full Text] [Related]
35. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis.
Naganuma M; Wiznerowicz EB; Lappas CM; Linden J; Worthington MT; Ernst PB
J Immunol; 2006 Sep; 177(5):2765-9. PubMed ID: 16920910
[TBL] [Abstract][Full Text] [Related]
36. Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.
Chhabra P; Wang K; Zeng Q; Jecmenica M; Langman L; Linden J; Ketchum RJ; Brayman KL
Cell Transplant; 2010; 19(5):597-612. PubMed ID: 20350347
[TBL] [Abstract][Full Text] [Related]
37. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
38. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
Front Immunol; 2018; 9():362. PubMed ID: 29545797
[TBL] [Abstract][Full Text] [Related]
39. Novel model of TH2-polarized chronic ileitis: the SAMP1 mouse.
McNamee EN; Wermers JD; Masterson JC; Collins CB; Lebsack MD; Fillon S; Robinson ZD; Grenawalt J; Lee JJ; Jedlicka P; Furuta GT; Rivera-Nieves J
Inflamm Bowel Dis; 2010 May; 16(5):743-52. PubMed ID: 19856411
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of intestinal lymphocyte activation and Th1 cytokine production by antibiotic therapy in a murine model of Crohn's disease.
Bamias G; Marini M; Moskaluk CA; Odashima M; Ross WG; Rivera-Nieves J; Cominelli F
J Immunol; 2002 Nov; 169(9):5308-14. PubMed ID: 12391251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
